Dr. Mark H. Widick, MD

Dr. Widick practices at ENT and Allergy Associates of Florida in Boca Raton, Florida.

Dr. Widick's NPI, 1871557629, was assigned on April 17, 2006. Dr. Widick graduated from University Of Florida College Of Medicine in 1987. Dr. Widick holds Florida license ME65602.

Dr. Widick's primary practice is ENT and Allergy Associates of Florida, at 900 NW 13th St, Boca Raton, FL 33486 in Palm Beach County. The practice phone is (561) 338-3267.

Dr. Widick's primary practice is ENT and Allergy Associates of Florida in Boca Raton, Florida. Dr. Widick is also affiliated with Boca Raton Regional Hospital. The medical group on file is ENT & Allergy Associates of Florida. Dmand AI also links Dr. Widick to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Widick practices, 2 sites in all. Vendor and product names are available with a free account.

Otology and neurotology is Dr. Widick's primary specialty in the NPI Registry, under taxonomy code 207YX0901X. Dr. Widick is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dmand AI has Dr. Widick's licenses on file in 2 states: Florida and Tennessee.

Dmand AI lists acute sinusitis, chronic ear infection, chronic nasal allergies, ear eustachian tube disorders, ear infection, hearing loss and impairment, larynx and vocal cord disease and swimmer's ear among the conditions Dr. Widick treats.

CMS data shows 2,901 Medicare services from Dr. Widick across 26 procedure codes in 2024, for 601 Medicare patients. Medicare paid $241,574 for them.

CMS counts 601 Medicare patients who saw Dr. Widick in 2024. The largest group is 75 to 84, with 245 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 2% are also on Medicaid. Their average risk score is 1.20, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Widick's median patient age at 70, with 56% women.

In 2024, Dr. Widick wrote 518 Medicare Part D claims for 212 patients. 99% of them were for generic drugs. CMS names the drug for 449 of them, across 12 drugs with 11 or more claims each, at $6,350 in total drug cost. In 2023, CMS named 328 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Widick for performance year 2024, reported individually. Dr. Widick accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 8 papers to Dr. Widick, published from 2017 to 2019. The most frequent topics are Ear Diseases, Dilatation and Ear, External. Dr. Widick has published most often in Am J Otol. Dr. Widick's most frequent co-authors are Moises Alberto Arriaga, MD, Neil E. Brown, MD and Marc Richard Dean, MD.

Dmand AI links Dr. Widick to 2 clinical trials. Conditions studied include Hearing Loss, Hidden, Tinnitus and Deafness.

CMS Open Payments shows 34 general payments to Dr. Widick from 12 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 52% of the total. Medical Device Business Services, Inc. paid the most, $815.

Dmand AI lists 4 awards for Dr. Widick, most recently Gulfstream FL-Palm Beach in 2014.

Dr. Widick graduated from University Of Florida College Of Medicine in 1987. Dr. Widick is a member of NHS.

Dr. Widick is in network with 16 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.